YNBY International Ltd.

YNBY International Ltd.

0030.HK
YNBY International Ltd.HK flagHong Kong Stock Exchange
0.27
HKD
- -
- -
2.07BMarket Cap
YNBY International Ltd.
0030.HK
(Hong Kong Stock Exchange)

Recent

price

0.27

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.26
0.19
0.17
0.06
0.04
0.03
0.05
0.09
0.16
0.16
0.18
0.19
0.03
0.07
0.11
0.15
Revenue per Share
-0.01
-0.04
0.02
-0.02
-0.01
-0.04
-0.01
-0.06
- -
0.01
0.01
-0.01
-0.17
-0.03
- -
- -
Basic EPS, GAAP
-0.01
-0.02
-0.12
-0.02
-0.01
-0.02
-0.06
-0.04
-0.04
-0.04
-0.01
-0.03
- -
-0.02
0.01
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.01
0.01
0.03
- -
-0.01
-0.05
-0.05
-0.09
-0.06
-0.04
-0.03
-0.04
-0.21
-0.15
-0.13
-0.12
Book Value per Share
0.1
0.23
-0.02
0.08
0.09
0.04
0.06
0.11
0.11
0.13
0.12
0.2
0.03
0.02
0.04
0.05
Tangible Book Value per Share
509
553
691
1,144
1,575
1,936
2,318
3,278
4,928
5,804
6,448
6,448
6,448
6,736
6,800
7,291
Basic Weighted Avg Shares
130
103
115
69
60
56
116
299
768
910
1,162
1,217
180
453
755
1,108
Sales/Revenue/Turnover
4.14
-5.43
-2.67
-29.21
-45.21
-58.12
-11.85
1.04
0.6
5.59
5.61
3.12
-607.71
-35.28
3.56
0.72
Operating Margin (%)
2
1
2
3
4
29
13
1
2
1
10
10
10
6
5
5
Depreciation Expense
-5
-23
13
-22
-23
-82
-34
-198
-1
44
50
-61
-1,117
-169
18
5
Net Income, GAAP
- -
- -
11.17
- -
- -
- -
- -
- -
- -
14.73
17.53
- -
- -
- -
24.13
52.11
Effective Tax Rate (%)
-4.04
-22.38
10.91
-32.38
-39.11
-145.9
-28.82
-66.12
-0.19
4.86
4.27
-5.04
-622.36
-37.29
2.4
0.41
Profit Margin (%)
50
128
-1
92
39
71
201
340
551
759
788
1,311
197
121
254
352
Working Capital
- -
- -
- -
- -
28
65
71
- -
- -
- -
5
21
3
11
6
4
LT Debt
51
130
306
416
461
423
434
344
557
765
801
1,310
203
113
260
358
Total Equity
- -
- -
-1.15
- -
- -
- -
- -
- -
- -
5.93
6.19
- -
- -
- -
10.16
1.2
Return on Invested Capital (%)
- -
- -
10.35
- -
- -
- -
- -
- -
- -
-26.66
-43.72
- -
- -
- -
-2.15
-0.55
Return on Capital (%)
-111.52
-442.91
107.72
-241.29
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
18.76%
20.4%
37.71%
Free Cash Flow
283.81%
500.62%
-381.16%
Net Income, GAAP
-155.01%
245.36%
-74.72%
Sales/Revenue/Turnover
65.14%
37.04%
46.79%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
453
2024
- -
- -
- -
- -
755
2025
- -
- -
- -
- -
1,108

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.03
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
YNBY International Ltd (0030.HK) is an investment holding company principally engaged in the trading of goods and commodities, with a focus on the health industry including e-commerce trading, raw materials sourcing for healthcare products, and distribution of branded healthcare items. Founded in 1971 and listed on the Hong Kong Stock Exchange in 1991, the company is headquartered at 32/F, Cambridge House, Taikoo Place, 979 King's Road, Quarry Bay, Hong Kong, and operates globally across Asia, America, and the EMEA region, with key activities in Hong Kong, the People's Republic of China, and international markets. Its core products and services encompass e-commerce sales of third-party branded goods on platforms such as VIP.com, JD.com, Tmall, Coupang, Lazada, and Shopee; trading of raw materials for healthcare and cosmetics including packaging materials, pharmacy and cosmetics materials, plant extracts, sorbitol, steviol glycoside, lauric acid, glycerin, and calcium hydrogen phosphate; distribution of YNBY Products such as the Yunnan Baiyao series medicines, toothpaste, general medicines, medical devices, industrial products, and personal care items under exclusive worldwide authorization (excluding PRC); and professional services including marketing, product and intellectual property registration, overseas market expansion, and sourcing for OEM/ODM. In 2022, Yunnan Baiyao Group Co., Ltd. became the controlling shareholder, driving a transformation toward health industry operations, including a framework agreement signed on 13 December 2022 for sourcing and distribution; the company changed its name from Ban Loong Holdings Ltd to YNBY International Ltd in September 2023; starting May 2023, it expanded distribution of YNBY Products to overseas markets, achieving the first sale of Thailand-manufactured Yunnan Baiyao toothpaste in the first half of 2025 as a milestone in international expansion; in May 2025, it placed 800 million new shares raising net proceeds of HK$92 million to fund ASEAN market development including product registration, marketing, and trading networks; and for the six months ended 30 June 2025, trading revenue rose 9.4% year-on-year to HK$396.4 million amid e-commerce and raw materials growth, with zero gearing and 35 employees.